Difference between revisions of "About-cancer/treatment/drugs/head-neck"
Jump to navigation
Jump to search
(Created page with "== Drugs Approved for Head and Neck Cancer == This page lists cancer drugs approved by the Food and Drug Administration (FDA) for cancer that arises in the head or neck regio...") |
|||
Line 1: | Line 1: | ||
+ | <languages/> | ||
+ | <translate> | ||
== Drugs Approved for Head and Neck Cancer == | == Drugs Approved for Head and Neck Cancer == | ||
Line 34: | Line 36: | ||
TPF | TPF | ||
+ | </translate> |
Revision as of 17:25, 28 October 2019
Drugs Approved for Head and Neck Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx [voice box]). The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in head and neck cancer that are not listed here.
Drugs Approved for Head and Neck Cancer
Bleomycin Sulfate
Cetuximab
Docetaxel
Erbitux (Cetuximab)
Hydrea (Hydroxyurea)
Hydroxyurea
Keytruda (Pembrolizumab)
Methotrexate
Nivolumab
Opdivo (Nivolumab)
Pembrolizumab
Taxotere (Docetaxel)
Trexall (Methotrexate)
Drug Combinations Used in Head and Neck Cancer
TPF